QUANTIFICATION OF HUMAN SERUM PARAOXONASE BY ENZYME-LINKED IMMUNOASSAY - POPULATION DIFFERENCES IN PROTEIN CONCENTRATIONS

被引:113
作者
GARIN, MCB [1 ]
ABBOTT, C [1 ]
MESSMER, S [1 ]
MACKNESS, M [1 ]
DURRINGTON, P [1 ]
POMETTA, D [1 ]
JAMES, RW [1 ]
机构
[1] UNIV MANCHESTER,ROYAL INFIRM,DEPT MED,MANCHESTER M13 9WL,LANCS,ENGLAND
关键词
D O I
10.1042/bj3040549
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Paraoxonase is a serum protein bound to high-density lipoproteins (HDLs). The physiological function of the enzyme is unknown, but a role in lipid metabolism has been postulated. To date, studies of the protein have had to rely on measurements of enzyme activity with various substrates. We have developed a highly specific, competitive e.l.i.s.a. using a previously characterized monoclonal antibody. The assay can detect 20 ng of paraoxonase with a working range of 75-600 ng. Intra- and interassay coefficients of variation were 6.5 and 7.9% respectively. Serum concentrations of paraoxonase in healthy subjects from Geneva and Manchester ranged from 25 to 118 mu g/ml. There were significant differences in mean concentrations between the two groups (Geneva, 79.3+/-18.7 mu g/ml; Manchester, 59.9+/-24.1 mu g/ml: P < 0.001), differences also apparent when subjects were compared according to paraoxonase phenotype. These appeared to be largely a consequence of differences in apolipoprotein A-I concentrations between the two populations, suggesting that HDL particle number may be important in determining serum levels of paraoxonase. Paraoxonase specific activities were also significantly different between the two groups of subjects (Geneva, 2.08+/-0.96 units/mg; Manchester, 3.08+/-1.73 units/mg: P < 0.001), which may reflect differences in HDL particle composition. The e.l.i.s.a. should furnish the necessary complement to studies of paraoxonase enzymic activity and has already provided evidence for differences with respect to serum levels of the protein both between populations and between phenotypes within populations.
引用
收藏
页码:549 / 554
页数:6
相关论文
共 34 条
  • [11] THE MOLECULAR-BASIS OF THE HUMAN SERUM PARAOXONASE ACTIVITY POLYMORPHISM
    HUMBERT, R
    ADLER, DA
    DISTECHE, CM
    HASSETT, C
    OMIECINSKI, CJ
    FURLONG, CE
    [J]. NATURE GENETICS, 1993, 3 (01) : 73 - 76
  • [12] IMMUNOFRACTIONATION OF HIGH-DENSITY-LIPOPROTEIN SUBCLASS-2 AND SUBCLASS-3 - SIMILARITIES AND DIFFERENCES OF FRACTIONS-ISOLATED FROM MALE AND FEMALE POPULATIONS
    JAMES, RW
    POMETTA, D
    [J]. ATHEROSCLEROSIS, 1990, 83 (01) : 35 - 45
  • [13] DIFFERENCES IN LIPOPROTEIN SUBFRACTION COMPOSITION AND DISTRIBUTION BETWEEN TYPE-I DIABETIC MEN AND CONTROL SUBJECTS
    JAMES, RW
    POMETTA, D
    [J]. DIABETES, 1990, 39 (10) : 1158 - 1164
  • [14] THE DISTRIBUTION PROFILES OF VERY LOW-DENSITY AND LOW-DENSITY LIPOPROTEINS IN POORLY-CONTROLLED MALE, TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    JAMES, RW
    POMETTA, D
    [J]. DIABETOLOGIA, 1991, 34 (04) : 246 - 252
  • [15] JAMES RW, 1988, J LIPID RES, V29, P1557
  • [16] KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41
  • [17] KUNITAKE ST, 1982, J LIPID RES, V23, P936
  • [18] La Du BN, 1992, PHARMACOGENETICS DRU, P51
  • [19] STUDIES ON HUMAN SERUM PARAOXONASE ARYLESTERASE
    LADU, BN
    ADKINS, S
    KUO, CL
    LIPSIG, D
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1993, 87 (1-3) : 25 - 34
  • [20] LADU BN, 1988, AM J HUM GENET, V43, P227